AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies https://ow.ly/Ql1K50RtqNW
AbCellera’s Post
More Relevant Posts
-
SPAC Feed: London SPAC Ashington Agrees to $171.5M Deal with Biotech Firm - https://lnkd.in/ezWNkiNM London-listed Ashington Innovation has agreed to a reverse takeover with a biotech firm less than two months after floating with… #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic
-
With biotech financing on the rise, early-stage companies have a few key opportunities to attract investors. We outline four in this checklist: https://hubs.la/Q02mJmXz0
-
-
Epoch 2: Biotech Poised for 2024 Recovery 👉First financing valuations 👉VC investment size and deal activity 👉Investment by indication 👉Most active biotech investors 👉Insider round prevalence 👉Avg valuations by round 👉Pharma VC impact on valuations 👉Private M&A 👉Techbio landscape 👉Techbio deal sizes 👉Techbio step-ups https://lnkd.in/dEkBy2bY
-
-
SPAC Feed: NKGen Biotech and Graf Acquisition Corp. IV Announce the … – GlobeNewswire - https://lnkd.in/gxWTBDjC NKGen Biotech and Graf Acquisition Corp. IV Announce the … GlobeNewswire Source: NKGen Biotech and Graf Acquisition Corp. IV Announce the… #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic
NKGen Biotech and Graf Acquisition Corp. IV Announce the … – GlobeNewswire
https://spacfeed.com
-
Fortress Biotech $FBIO - Interview with Founder and CEO Lindsay Rosenwald. Lindsay has created and sold numerous biotech companies including Cougar Tech to Johnson & Johnson for $1 billion in 2009. In the interview, we discuss: - Fortress Biotech's diversified business model - Lindsay's views and predictions for Biotech in 2024 - Why Lindsay purchased $2m of $FBIO stock https://lnkd.in/eQZRXFJD Take a look and let me know what you think!
-
Growth Opportunities in Global Biotech Investment, 2024 🌍 Discover how disruptive technologies and strategic portfolio realignment by major biopharma companies are shaping the future of biotech investments. 💡Key Developments: - Biotech M&A and VC investment trends - Drivers and challenges in the biotech sector - Impact of cash availability and the patent cliff Unlock the full potential of biotech investments with our latest analysis! 🔗 https://hubs.ly/Q02G8-lv0 #BiotechInvestment #PharmaInnovation #MergersAndAcquisitions #VentureCapital
-
-
Get smarter. PIPE financings are happening left and right in biotech right now, and many don’t really know what they are and how they differ from traditional follow-on financings. STAT’s Adam Feuerstein wrote an explainer you’ll be happy you read.
An inside look at PIPEs, the financing trend that has biotech abuzz
https://www.statnews.com
-
SFBN Feed: Is biotech ready for a return of the IPO? There are signs of a thaw. https://lnkd.in/gWrHbwBd Twenty to 30 life sciences IPO a year is “pretty reasonable,” says an analyst, compared to more than 100 in 2021. Click here to view original post #BayArea #SanFrancisco #Biotech #Lifescience #News
Is biotech ready for a return of the IPO? There are signs of a thaw.
https://sfbn.org
-
Growth Opportunities in Global Biotech Investment, 2024 🌍 Discover how disruptive technologies and strategic portfolio realignment by major biopharma companies are shaping the future of biotech investments. 💡Key Developments: - Biotech M&A and VC investment trends - Drivers and challenges in the biotech sector - Impact of cash availability and the patent cliff Unlock the full potential of biotech investments with our latest analysis! 🔗 https://hubs.ly/Q02G8-Pm0 #BiotechInvestment #PharmaInnovation #MergersAndAcquisitions #VentureCapital
-
Congratulations on this creative initiative! Cheering for you, AbCellera team!